Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0M4YV | ISIN: CNE100000411 | Ticker-Symbol: XIN
Frankfurt
21.11.24
08:08 Uhr
0,695 Euro
0,000
0,00 %
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANDONG XINHUA PHARMACEUTICAL CO LTD Chart 1 Jahr
5-Tage-Chart
SHANDONG XINHUA PHARMACEUTICAL CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,7000,75013:17

Aktuelle News zur SHANDONG XINHUA PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.11.SHANDONG XINHUA (00719): REPLY SLIP FOR THE SECOND EXTRAORDINARY GENERAL MEETING FOR THE YEAR 2024-
13.11.SHANDONG XINHUA (00719): PROXY FORM FOR THE SECOND EXTRAORDINARY GENERAL MEETING FOR THE YEAR 2024-
13.11.SHANDONG XINHUA (00719): NOTICE OF EXTRAORDINARY GENERAL MEETING-
13.11.SHANDONG XINHUA (00719): (1) CONTINUING CONNECTED TRANSACTIONS; AND (2) NOTICE OF EXTRAORDINARY GENERAL MEETING-
11.11.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON FEBUXOSTAT TABLETS HAVING OBTAINED THE DRUG REGISTRATION CERTIFICATE-
SHANDONG XINHUA PHARMACEUTICAL Aktie jetzt für 0€ handeln
05.11.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON CALCIUM GLUCONATE INJECTION PASSING THE GENERICS CONSISTENCY EVALUATION1
04.11.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON DRUGS OF WHOLLY-OWNED SUBSIDIARY PASSING THE GENERICS CONSISTENCY EVALUATION-
04.11.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON PENTAZOCINE HAVING OBTAINED THE NOTIFICATION OF APPROVAL OF MARKETING APPLICATION ...-
29.10.SHANDONG XINHUA (00719): RENEWAL OF CONTINUING CONNECTED TRANSACTIONS AND RELATED PARTY TRANSACTION AND ENTERING INTO OF CONTINUING CONNECTED TRANSACTIONS1
29.10.SHANDONG XINHUA (00719): ANNOUNCEMENT ON ABSORPTION AND MERGER OF WHOLLY-OWNED SUBSIDIARY4
29.10.SHANDONG XINHUA (00719): UNAUDITED QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER 20241
28.10.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON HAVING OBTAINED THE NOTIFICATION OF APPROVAL OF SUPPLEMENTARY DRUG APPLICATION ...3
28.10.SHANDONG XINHUA (00719): OVERSEAS REGULATORY ANNOUNCEMENT-ANNOUNCEMENT ON HAVING OBTAINED FDA APPROVAL OF ABBREVIATED NEW DRUG APPLICATION (ANDA)-
25.10.SHANDONG XINHUA (00719): ARTICLES OF ASSOCIATION-
25.10.SHANDONG XINHUA (00719): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING4
14.10.SHANDONG XINHUA (00719): ANNOUNCEMENT NOTICE OF BOARD MEETING-
03.10.SHANDONG XINHUA (00719): REPLY SLIP FOR THE FIRST EXTRAORDINARY GENERAL MEETING FOR THE YEAR 20242
03.10.SHANDONG XINHUA (00719): PROXY FORM FOR THE FIRST EXTRAORDINARY GENERAL MEETING FOR THE YEAR 20241
03.10.SHANDONG XINHUA (00719): NOTICE OF EXTRAORDINARY GENERAL MEETING2
03.10.SHANDONG XINHUA (00719): PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION, THE RULES AND PROCEDURES FOR GENERAL MEETINGS, THE RULES AND PROCEDURES FOR ...1
Seite:  Weiter >>
44 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1